ERBB2 and neoplasm: Similarly, the tumor inflammation signature (TIS) score, was not associated with relapse (p-value 0.678), and normalized counts for the ERBB2 gene did not significantly differ between relapsed (median value 1.6, IQ–IIIQ: 0.5–3.3) and not relapsed patients (median value 2.5, IQ–IIIQ: 0.4–4.1), with a p-value = 0.245.